发明名称 Novel aminobenzamide derivative
摘要 This invention relates to a novel compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein R<SUP>1 </SUP>is -S(O)p-A, -S-(O)q-B or -O-D, wherein p and q, which are the same or different, each represent an integer from 0 to 2, A is a straight chain C1-C10 alkyl group which may be substituted by R<SUP>10</SUP>, and B and D each independently represent R<SUP>12 </SUP>which may be substituted by R<SUP>10</SUP>; R<SUP>2 </SUP>is a hydrogen atom, a halogen atom, or a straight chain or branched C1-C6 alkyl group which may be substituted by R<SUP>10</SUP>; X<SUP>1 </SUP>and X<SUP>2 </SUP>each independently represent N or CH, but cannot both be N; the formula (II): shows a monocyclic or bicyclic heteroaryl group which has a nitrogen atom adjacent to the carbon atom bonded to the amide group, and the heteroaryl group may be substituted by R<SUP>10</SUP>; R<SUP>10 </SUP>is R<SUP>11</SUP>, or a hydrocarbon group which may be substituted by R<SUP>11</SUP>; R<SUP>11 </SUP>is, for example, a hydrogen atom or amino; and R<SUP>12 </SUP>is, for example, phenyl, thiazolyl, pyridyl or methylene dioxyphenyl. The compound according to this invention has a glucokinase activation effect, and for example, is useful in the treatment and prevention of diabetes mellitus, and in the prevention of its complications such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy and diabetic arteriosclerosis.
申请公布号 US2005282815(A1) 申请公布日期 2005.12.22
申请号 US20040952471 申请日期 2004.09.27
申请人 BANYU PHARMACEUTICAL CO., LTD. 发明人 NISHIMURA TERUYUKI;IINO TOMOHARU;NAGATA YASUFUMI;EIKI JUN-ICHI
分类号 A61K31/426;A61K31/427;A61K31/433;A61K31/437;A61K31/4439;A61K31/506;A61P3/04;A61P3/10;A61P43/00;C07D277/46;C07D277/56;C07D401/12;C07D417/06;C07D417/12;C07D417/14;C07D513/04;(IPC1-7):A61K31/506;A61K31/501;A61K31/497;A61K31/443;C07D417/02;C07D413/02;C07D43/02 主分类号 A61K31/426
代理机构 代理人
主权项
地址